Beta-2 adrenergic receptor
Assets acting on this target.
- Class
- Beta-2 adrenergic receptor agonist
- Pathway
- airway smooth-muscle relaxation / bronchodilation
- Notes
- original target text: β2-adrenergic receptor
The beta-2 adrenergic receptor is a cell-surface receptor found abundantly on the smooth muscle that surrounds airways in the lungs. It belongs to the G protein-coupled receptor family, and its natural ligands are adrenaline and, to a lesser extent, noradrenaline. When activated, this receptor triggers relaxation of airway smooth muscle, which widens the airway lumen and eases airflow. This effect is exploited pharmacologically through beta-2 agonists, small molecules that mimic the natural ligand at this receptor. Short-acting agonists produce rapid but relatively brief bronchodilation, useful for quickly relieving acute breathlessness, while long-acting agonists provide more sustained relaxation for ongoing symptom control. Because the receptor also exists in other tissues, agonism is not perfectly confined to the lungs, which underlies some of the class's known side effects. This mechanism is central to managing obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD), where narrowed airways from smooth-muscle contraction, inflammation, and mucus contribute to breathing difficulty. Beta-2 agonists are frequently combined with inhaled corticosteroids, which address underlying airway inflammation, or with agents that block a different receptor pathway (muscarinic antagonists), reflecting the complementary, multi-pathway nature of airway disease management.
By indication
Related mechanisms
Beta-2 adrenergic receptor drugs compared
17 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Aclidinium bromide/formoterol fumarateDuaklir Pressair | Almirall, Azurity Pharmaceuticals | small molecule combination | Approved | Approved in Chronic Obstructive Pulmonary Disease |
| albuterol (Armstrong Albuterol HFA) | Amphastar Pharmaceuticals, Inc. | small molecule | Approved | Approved in Asthma |
| albuterol (Ventolin)Ventolin | GlaxoSmithKline | small molecule | Approved | Approved in Asthma |
| albuterol / budesonideAirsupra | AstraZeneca | combination (SABA + ICS) | Approved | Approved in Asthma |
| albuterol sulfate (Amphastar) | Amphastar Pharmaceuticals, Inc. | small molecule | Approved | Approved in Asthma |
| Albuterol sulfate (Proventil HFA)Proventil HFA | Kindeva Drug Delivery, Sandoz Group AG | small molecule | Approved | Approved in Asthma |
| fluticasone furoate/umeclidinium/vilanterolTrelegy Ellipta | GlaxoSmithKline | small molecule combination | Approved | Approved in Asthma; Approved in Chronic Obstructive Pulmonary Disease |
| fluticasone furoate/vilanterolBreo Ellipta | GlaxoSmithKline | small molecule combination | Approved | Approved in Asthma; Approved in Chronic Obstructive Pulmonary Disease |
| Fluticasone propionate/salmeterol (Advair HFA)Advair HFA | GlaxoSmithKline | combination (ICS + LABA) | Approved | Approved in Asthma |
| Glycopyrrolate/formoterol fumarateBevespi Aerosphere | AstraZeneca | small molecule combination | Approved | Approved in Chronic Obstructive Pulmonary Disease |
| Olodaterol | Boehringer Ingelheim | small molecule | Approved | Approved in Chronic Obstructive Pulmonary Disease |
| Olodaterol/tiotropium bromide | Boehringer Ingelheim | small molecule combination | Approved | Approved in Chronic Obstructive Pulmonary Disease |
| Salmeterol (DISKUS) | GlaxoSmithKline | small molecule | Approved | Approved in Asthma; Approved in Chronic Obstructive Pulmonary Disease |
| Umeclidinium/Vilanterol | GlaxoSmithKline, Innoviva, Sino Biopharmaceutical | small molecule combination | Approved | Approved in Chronic Obstructive Pulmonary Disease |
| fenoterol | Boehringer Ingelheim | small molecule | Phase 3 | Phase 3 in Asthma |
| Salbutamol HFA-152a | GlaxoSmithKline | small molecule | Phase 3 | Phase 3 in Asthma |
| Vilanterol | GlaxoSmithKline | small molecule | Phase 3 | Phase 3 in Asthma |